The company is committed to developing novel research technologies to manufacture biological substances including recombinant protein, recombinant antibody,protein production service,enzyme and antibodies for applications in biomedical research and clinical diagnosis.
The company is now establishing an innovative and dynamic R&D team and a state of the art biotechnology facility to develop biologics for the growing market needs in clinical diagnosis. The research team of the company provide contract research service to pharmaceutical and academic research organizations, specifically in gene cloning, plasmids construction and mutagenesis, protein expression in E. coli and mammalian cell systems, purification and characterization. The company supports customer to screen, isolate and identify high expression stable cell line for protein and antibody manufacturing.

The concept of recombinant proteins

Recombinant protein is a synthetic protein that code is carried by the recombinant DNA. Know the protein encoded in the gene sequence, the artificial cloning of the gene into the plasmid. And then plasmid such as E. coli. This protein expression in E. coli has become the factory. Expressed protein purification and then been to, is the recombinant protein. Recombinant proteins from genetically modified animals generally produce breast to produce recombinant protein biopharmaceuticals in medicine as a significant effect. The recombinant protein can be a variety of types, antibodies, antigens, hormones and enzymes. Successful expression and purification of recombinant proteins is dependent on a powerful and efficient proteomics workflow. From small to large-scale studies, our reagents, kits and carriers, designed to address, including protein expression, induce cell lysis / extraction, capture and purification needs.
Preparation of recombinant antibody technology to make humanized antibodies and humanized antibodies as possible, and that other conventional polyclonal or monoclonal antibody method impossible. The manufacture of recombinant antibody production time is relatively short, the end product of high quality. The company has the top of the recombinant protein preparation of technical personnel and improve the production equipment, molecular biology experiments in the overall design and optimization, cell lines expressing recombinant antibody construct, antibody humanized transformation, efficient eukaryotic expression technology, serum-free culture technology, nursing technology and other large-scale cultivation of animal cells has a significant advantage.